Endothelial cells and VEGF in vascular development

Nature

Volumn 438, Issue 7070, 2005, Pages 937-945

  Coultas, Leigh ^a   Chawengsaksophak, Kallayanee ^a   Rossant, Janet ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CARDIOVASCULAR SYSTEM; CHEMOTHERAPY; ENVIRONMENTAL IMPACT; PARAMETER ESTIMATION;

ENDOTHELIAL CELLS; VASCULAR DEVELOPMENTS;

CELLS;

ANGIOGENIC FACTOR; ANGIOPOIETIN; BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN 4; NOTCH RECEPTOR; TIE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

CELLS AND CELL COMPONENTS;

AMYOTROPHIC LATERAL SCLEROSIS; BONE; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CIRCULATION; DRUG TARGETING; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; GENE DISRUPTION; GLOMERULUS; HEMATOPOIETIC STEM CELL; HUMAN; LIVER; LYMPHANGIOGENESIS; MYOBLAST; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; ORGANOGENESIS; PANCREAS; PERICYTE; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SMOOTH MUSCLE FIBER; SPINAL CORD INJURY; STEM CELL; VASCULARIZATION;

EID: 30744432619     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature04479     Document Type: Review

References (100)

1. Carmeliet, P. Angiogenesis in health and disease. Nature Med. 9, 653-660 (2003).
2. Rossant, J. & Howard, L. Signaling pathways in vascular development. Annu. Rev. Cell Dev. Biol. 18, 541-573 (2002).
3. Bikfalvi, A. & Bicknell, R. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. Trends Pharmacol. Sci. 23, 576-582 (2002).
4. Thurston, G. Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res. 314, 61-68 (2003).
5. Betsholtz, C., Lindblom, P. & Gerhardt, H. Role of pericytes in vascular morphogenesis. EXS 115-125 (2005).
6. Lebrin, F., Deckers, M., Bertolino, P. & Ten Dijke, P. TGF-M receptor function in the endothelium. Cardiovasc. Res. 65, 599-608 (2005).
7. Shalaby, F. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66 (1995).
8. Shalaby, F. et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89, 981-990 (1997).
9. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439 (1996).
10. Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442 (1996).
11. Ema, M. & Rossant, J. Cell fate decisions in early blood vessel formation. Trends Cardiovasc. Med. 13, 254-259 (2003).
12. Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C. & Keller, G. A common precursor for hematopoietic and endothelial cells. Development 125, 725-732 (1998).
13. Chung, Y. S. et al. Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression. Development 129, 5511-5520 (2002).
14. Huber, T. L., Kouskoff, V., Fehling, H. J., Palis, J. & Keller, G. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 432, 625-630 (2004).
15. Yamashita, J. et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408, 92-96 (2000).
16. Ema, M. et al. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev. 17, 380-393 (2003).
17. Schroeder, T. et al. Recombination signal sequence-binding protein Jg alters mesodermal cell fate decisions by suppressing cardiomyogenesis. Proc. Natl Acad. Sci. USA 100, 4018-4023 (2003).
18. Jiang, Y. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49 (2002).
19. Minasi, M. G. et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129, 2773-2783 (2002).
20. Kinder, S. J., Loebel, D. A. & Tam, P. P. Allocation and early differentiation of cardiovascular progenitors in the mouse embryo. Trends Cardiovasc. Med. 11, 177-184 (2001).
21. Ferkowicz, M. J. et al. CD41 expression defines the onset of primitive and definitive hematopoiesis in the murine embryo. Development 130, 4393-4403 (2003).
22. Jones, E. A. et al. Dynamic in vivo imaging of postimplantation mammalian embryos using whole embryo culture. Genesis 34, 228-235 (2002).
23. Ramirez-Bergeron, D. L. et al. Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development 131, 4623-4634 (2004).
24. le Noble, F. et al. Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development 131, 361-375 (2004).
25. Adams, R. H. et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13, 295-306 (1999).
26. Wang, H. U., Chen, Z. F. & Anderson, D. J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753 (1998).
27. Gerety, S. S., Wang, H. U., Chen, Z. F. & Anderson, D. J. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell 4, 403-414 (1999).
28. Herzog, Y., Guttmann-Raviv, N. & Neufeld, G. Segregation of arterial and venous markers in subpopulations of blood islands before vessel formation. Dev. Dyn. 232, 1047-1055 (2005).
29. Zhong, T. P., Childs, S., Leu, J. P. & Fishman, M. C. Gridlock signalling pathway fashions the first embryonic artery. Nature 414, 216-220 (2001).
30. Moyon, D., Pardanaud, L., Yuan, L., Breant, C. & Eichmann, A. Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development 128, 3359-3370 (2001).
31. Isogai, S., Lawson, N. D., Torrealday, S., Horiguchi, M. & Weinstein, B. M. Angiogenic network formation in the developing vertebrate trunk. Development 130, 5281-5290 (2003).
32. Lawson, N. D. et al. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128, 3675-3683 (2001).
33. Zhong, T. P., Rosenberg, M., Mohideen, M. A., Weinstein, B. & Fishman, M. C. gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287, 1820-1824 (2000).
34. Nye, J. S. & Kopan, R. Developmental signaling. Vertebrate ligands for Notch. Curr. Biol. 5, 966-969 (1995).
35. Duarte, A. et al. Dosage-sensitive requirement for mouse DII4 in artery development. Genes Dev. 18, 2474-2478 (2004).
36. Gale, N. W. et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl. Acad. Sci. USA 101, 15949-15954 (2004).
37. Krebs, L. T. et al. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 18, 2469-2473 (2004).
38. Fischer, A., Schumacher, N., Maier, M., Sendtner, M. & Gessler, M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18, 901-911 (2004).
39. You, L. R. et al. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435, 98-104 (2005).
40. Fouquet, B., Weinstein, B. M., Serluca, F. C. & Fishman, M. C. Vessel patterning in the embryo of the zebrafish: guidance by notochord. Dev. Biol. 183, 37-48 (1997).
41. Sumoy, L., Keasey, J. B., Dittman, T. D. & Kimelman, D. A role for notochord in axial vascular development revealed by analysis of phenotype and the expression of VEGR-2 in zebrafish flh and ntl mutant embryos. Mech. Dev. 63, 15-27 (1997).
42. Cleaver, O. & Krieg, P. A. VEGF mediates angioblast migration during development of the dorsal aorta in Xenopus. Development 125, 3905-3914 (1998).
43. Cleaver, O. & Krieg, P. A. Notochord patterning of the endoderm. Dev. Biol. 234, 1-12 (2001).
44. Miquerol, L., Gertsenstein, M., Harpal, K., Rossant, J. & Nagy, A. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. Dev. Biol. 212, 307-322 (1999).
45. Liang, D. et al. The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech. Dev. 108, 29-43 (2001).
46. Vokes, S. A. et al. Hedgehog signaling is essential for endothelial tube formation during vasculogenesis. Development 131, 4371-4380 (2004).
47. Hogan, K. A. & Bautch, V. L. Blood vessel patterning at the embryonic midline. Curr. Top. Dev. Biol. 62, 55-85 (2004).
48. Reese, D. E., Hall, C. E. & Mikawa, T. Negative regulation of midline vascular development by the notochord. Dev. Cell 6, 699-708 (2004).
49. Nimmagadda, S. et al. BMP4 and noggin control embryonic blood vessel formation by antagonistic regulation of VEGFR-2 (Quek1) expression. Dev. Biol. 280, 100-110 (2005).
50. Hogan, K. A., Ambler, C. A., Chapman, D. L. & Bautch, V. L. The neural tube patterns vessels developmentally using the VEGF signaling pathway. Development 131, 1503-1513 (2004).
51. Nagase, T., Nagase, M., Yoshimura, K., Fujita, T. & Koshima, I. Angiogenesis within the developing mouse neural tube is dependent on sonic hedgehog signaling: possible roles of motor neurons. Genes Cells 10, 595-604 (2005).
52. Coffin, J. D. & Poole, T. J. Embryonic vascular development: immunohistochemical identification of the origin and subsequent morphogenesis of the major vessel primordia in quail embryos. Development 102, 735-748 (1988).
53. Kearney, J. B., Kappas, N. C., Ellerstrom, C., DiPaola, F. W. & Bautch, V. L. The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. Blood 103, 4527-4535 (2004).
54. Krebs, L. T. et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14, 1343-1352 (2000).
55. Carmeliet, P. & Tessier-Lavigne, M. Common mechanisms of nerve and blood vessel wiring. Nature 436, 193-200 (2005).
56. Nikolova, G. & Lammert, E. Interdependent development of blood vessels and organs. Cell Tissue Res. 314, 33-42 (2003).
57. Matsumoto, K., Yoshitomi, H., Rossant, J. & Zaret, K. S. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294, 559-563 (2001).
58. LeCouter, J. et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 299, 890-893 (2003).
59. Lammert, E., Cleaver, O. & Melton, D. Induction of pancreatic differentiation by signals from blood vessels. Science 294, 564-567 (2001).
60. Lammert, E. et al. Role of VEGF-A in vascularization of pancreatic islets. Curr. Biol. 13, 1070-1074 (2003).
61. Yoshitomi, H. & Zaret, K. S. Endothelial cell interactions initiate dorsal pancreas development by selectively inducing the transcription factor Ptf1a. Development 131, 807-817 (2004).
62. Field, H. A., Ober, E. A., Roeser, T. & Stainier, D. Y. Formation of the digestive system in zebrafish. I. Liver morphogenesis. Dev. Biol. 253, 279-290 (2003).
63. Field, H. A., Dong, P. D., Beis, D. & Stainier, D. Y. Formation of the digestive system in zebrafish. II. Pancreas morphogenesis. Dev. Biol. 261, 197-208 (2003).
64. Lemaigre, F. & Zaret, K. S. Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr. Opin. Genet. Dev. 14, 582-590 (2004).
65. Eremina, V. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707-716 (2003).
66. Mattot, V. et al. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J. Am. Soc. Nephrol. 13, 1548-1560 (2002).
67. Bjarnegard, M. et al. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 131, 1847-1857 (2004).
68. Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658 (2003).
69. Rossant, J. & Cross, J. C. Placental development: lessons from mouse mutants. Nature Rev. Genet. 2, 538-548 (2001).
70. Jackson, D., Volpert, O. V., Bouck, N. & Linzer, D. I. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science 266, 1581-1584 (1994).
71. Carmeliet, P. et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nature Med. 7, 575-583 (2001).
72. Autiero, M. et al. Role of PIGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nature Med. 9, 936-943 (2003).
73. Hirashima, M., Lu, Y., Byers, L. & Rossant, J. Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta. Proc. Natl Acad. Sci. USA 100, 15637-15642 (2003).
74. Redman, C. W. & Sargent, I. L. Latest advances in understanding preeclampsia. Science 308, 1592-1594 (2005).
75. Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl. J. Med. 350, 672-683 (2004).
76. Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836-841 (2003).
77. Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841-846 (2003).
78. Avecilla, S. T. et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nature Med. 10, 64-71 (2004).
79. Rafii, S. et al. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 86, 3353-3363 (1995).
80. Mohle, R., Green, D., Moore, M. A., Nachman, R. L. & Rafii, S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl Acad. Sci. USA 94, 663-668 (1997).
81. Li, W., Johnson, S. A., Shelley, W. C. & Yoder, M. C. Hematopoietic stem cell repopulating ability can be maintained in vitro by some primary endothelial cells. Exp. Hematol. 32, 1226-1237 (2004).
82. Kiel, M. J. et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109-1121 (2005).
83. Rafii, S. & Lyden, D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nature Med. 9, 702-712 (2003).
84. Storkebaum, E. & Carmeliet, P. VEGF: a critical player in neurodegeneration. J. Clin. Invest. 113, 14-18 (2004).
85. Oosthuyse, B. et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nature Genet. 28, 131-138 (2001).
86. Storkebaum, E. et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nature Neurosci. 8, 85-92 (2005).
87. Schwarz, Q. et al. Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve. Genes Dev. 18, 2822-2834 (2004).
88. Haigh, J. J. et al. Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev. Biol. 262, 225-241 (2003).
89. Rosenstein, J. M. & Krum, J. M. New roles for VEGF in nervous tissue - beyond blood vessels. Exp. Neurol. 187, 246-253 (2004).
90. Gerber, H. P. et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nature Med. 5, 623-628 (1999).
91. Maes, C. et al. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech. Dev. 111, 61-73 (2002).
92. Zelzer, E. et al. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129, 1893-1904 (2002).
93. Maes, C. et al. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J. Clin. Invest. 113, 188-199 (2004).
94. Zelzer, E. et al. VEGFA is necessary for chondrocyte survival during bone development. Development 131, 2161-2171 (2004).
95. Street, J. et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl Acad Sci. USA 99, 9656-9661 (2002).
96. Nakagawa, M. et al. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett. 473, 161-164 (2000).
97. Gerber, H. P. et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417, 954-958 (2002).
98. Arsic, N. et al. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol. Ther. 10, 844-854 (2004).
99. Compernolle, V. et al. Loss of HIF-24 and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nature Med. 8, 702-710 (2002).
100. Sharpe, J. et al. Optical projection tomography as a tool for 3D microscopy and gene expression studies. Science 296, 541-545 (2002).